Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „should“
Suchtreffer
Begriffe & Kennungen
Buvidal · 4.5 · Buprenorphine should be used cautiously when co-administered with: • naltrexone and nalmefene: These are opioi
Eintrag öffnenBuvidal · 4.5 · Buprenorphine should be used cautiously when co-administered with: • naltrexone and nalmefene: These are opioi
Eintrag öffnenBysumlog · 4.5 · The physician should be consulted when using other medications in addition to Bysumlog (see section 4.4).
Eintrag öffnenCalquence · 4.5 · Concomitant use with strong CYP3A/P-gp inhibitors should be avoided. If the strong CYP3A/P-gp inhibitors (e.g.
Eintrag öffnenCalquence · 4.5 · Concomitant use with strong CYP3A/P-gp inhibitors should be avoided. If the strong CYP3A/P-gp inhibitors (e.g.
Eintrag öffnenCalquence · 4.5 · Concomitant use with strong inducers of CYP3A activity (e.g., phenytoin, rifampicin, carbamazepine) should be
Eintrag öffnenCalquence · 4.5 · Concomitant use with strong inducers of CYP3A activity (e.g., phenytoin, rifampicin, carbamazepine) should be
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.5 · Due to the potential sensitivity of rapidly dividing myeloid cells to cytotoxic chemotherapy‚ Cegfila should b
Eintrag öffnenCellCept · 4.3 · 25 • Treatment should not be used in pregnancy unless there is no suitable alternative treatment to prevent tr
Eintrag öffnenCellCept · 4.3 · • CellCept should not be given to patients with hypersensitivity to mycophenolate mofetil, mycophenolic acid o
Eintrag öffnenCellCept · 4.3 · • CellCept should not be given to patients with hypersensitivity to mycophenolate mofetil, mycophenolic acid o
Eintrag öffnenCellCept · 4.3 · • CellCept should not be given to patients with hypersensitivity to mycophenolate mofetil, mycophenolic acid o
Eintrag öffnenCellCept · 4.3 · • CellCept should not be given to patients with hypersensitivity to mycophenolate mofetil, mycophenolic acid o
Eintrag öffnenCellCept · 4.3 · • Treatment should not be given to patients who are allergic to polysorbate 80.
Eintrag öffnenCellCept · 4.3 · • Treatment should not be given to women of childbearing potential who are not using highly effective contrace
Eintrag öffnenCellCept · 4.3 · • Treatment should not be given to women of childbearing potential who are not using highly effective contrace
Eintrag öffnenCellCept · 4.3 · • Treatment should not be given to women of childbearing potential who are not using highly effective contrace
Eintrag öffnenCellCept · 4.3 · • Treatment should not be given to women of childbearing potential who are not using highly effective contrace
Eintrag öffnenCellCept · 4.3 · • Treatment should not be given to women who are breastfeeding (see section 4.6).
Eintrag öffnenCellCept · 4.3 · • Treatment should not be given to women who are breastfeeding (see section 4.6).
Eintrag öffnen